195 related articles for article (PubMed ID: 28475854)
1. Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.
Brubaker WD; Crane A; Johansson JU; Yen K; Garfinkel K; Mastroeni D; Asok P; Bradt B; Sabbagh M; Wallace TL; Glavis-Bloom C; Tenner AJ; Rogers J
Alzheimers Dement; 2017 Dec; 13(12):1397-1409. PubMed ID: 28475854
[TBL] [Abstract][Full Text] [Related]
2. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy.
Crane A; Brubaker WD; Johansson JU; Trigunaite A; Ceballos J; Bradt B; Glavis-Bloom C; Wallace TL; Tenner AJ; Rogers J
Alzheimers Dement; 2018 Feb; 14(2):243-252. PubMed ID: 28755839
[TBL] [Abstract][Full Text] [Related]
3. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
Johansson JU; Brubaker WD; Javitz H; Bergen AW; Nishita D; Trigunaite A; Crane A; Ceballos J; Mastroeni D; Tenner AJ; Sabbagh M; Rogers J
Alzheimers Dement; 2018 Nov; 14(11):1438-1449. PubMed ID: 29792870
[TBL] [Abstract][Full Text] [Related]
4. Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes.
Rogers J; Li R; Mastroeni D; Grover A; Leonard B; Ahern G; Cao P; Kolody H; Vedders L; Kolb WP; Sabbagh M
Neurobiol Aging; 2006 Dec; 27(12):1733-9. PubMed ID: 16290270
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia.
Lauriola M; Paroni G; Ciccone F; D Onofrio G; Cascavilla L; Paris F; Gravina C; Urbano M; Seripa D; Greco A
Curr Alzheimer Res; 2018 Feb; 15(4):381-385. PubMed ID: 29125073
[TBL] [Abstract][Full Text] [Related]
7. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte Amyloid Beta Peptide Isoform Distributions in Alzheimer and Mild Cognitive Impairment.
Järemo P; Jejcic A; Jelic V; Shahnaz T; Oweling M; Winblad B; Behbahani H
Curr Alzheimer Res; 2019; 16(11):1050-1054. PubMed ID: 31660827
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
10. RIG-1 receptor expression in the pathology of Alzheimer's disease.
de Rivero Vaccari JP; Brand FJ; Sedaghat C; Mash DC; Dietrich WD; Keane RW
J Neuroinflammation; 2014 Apr; 11():67. PubMed ID: 24694234
[TBL] [Abstract][Full Text] [Related]
11. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.
Li J; Wang JP; Ghiran I; Cerny A; Szalai AJ; Briles DE; Finberg RW
Infect Immun; 2010 Jul; 78(7):3129-35. PubMed ID: 20439480
[TBL] [Abstract][Full Text] [Related]
12. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
13. IgM response against amyloid-beta in aging: a potential peripheral protective mechanism.
Agrawal S; Abud EM; Snigdha S; Agrawal A
Alzheimers Res Ther; 2018 Aug; 10(1):81. PubMed ID: 30115117
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
15. A complex proinflammatory role for peripheral monocytes in Alzheimer's disease.
Saresella M; Marventano I; Calabrese E; Piancone F; Rainone V; Gatti A; Alberoni M; Nemni R; Clerici M
J Alzheimers Dis; 2014; 38(2):403-13. PubMed ID: 23979026
[TBL] [Abstract][Full Text] [Related]
16. Amyloid peptide inhibits ATP release from human erythrocytes.
Misiti F; Orsini F; Clementi ME; Masala D; Tellone E; Galtieri A; Giardina B
Biochem Cell Biol; 2008 Dec; 86(6):501-8. PubMed ID: 19088798
[TBL] [Abstract][Full Text] [Related]
17. Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease.
Kristofikova Z; Ricny J; Kolarova M; Vyhnalek M; Hort J; Laczo J; Sirova J; Ripova D
J Alzheimers Dis; 2014; 42 Suppl 3():S91-8. PubMed ID: 24670397
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.
Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH
J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658
[TBL] [Abstract][Full Text] [Related]
19. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor.
Xie L; Helmerhorst E; Taddei K; Plewright B; Van Bronswijk W; Martins R
J Neurosci; 2002 May; 22(10):RC221. PubMed ID: 12006603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
